ADX-324

· ADARx Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ADX-324, covering 2026-03-02 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients [Phase 1, Phase 2]

See pricing